Kala Bio Inc (KALA)
6.52
+0.12
(+1.88%)
USD |
NASDAQ |
Apr 25, 11:38
Kala Bio Cash from Operations (TTM): -27.93M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.93M |
| September 30, 2023 | -33.97M |
| June 30, 2023 | -46.68M |
| March 31, 2023 | -64.50M |
| December 31, 2022 | -78.91M |
| September 30, 2022 | -93.08M |
| June 30, 2022 | -103.50M |
| March 31, 2022 | -99.68M |
| December 31, 2021 | -108.24M |
| September 30, 2021 | -106.25M |
| June 30, 2021 | -105.81M |
| March 31, 2021 | -103.45M |
| December 31, 2020 | -90.69M |
| September 30, 2020 | -82.99M |
| June 30, 2020 | -80.26M |
| Date | Value |
|---|---|
| March 31, 2020 | -81.43M |
| December 31, 2019 | -92.72M |
| September 30, 2019 | -90.50M |
| June 30, 2019 | -83.80M |
| March 31, 2019 | -72.58M |
| December 31, 2018 | -54.12M |
| September 30, 2018 | -44.70M |
| June 30, 2018 | -37.81M |
| March 31, 2018 | -37.46M |
| December 31, 2017 | -34.10M |
| September 30, 2017 | -34.86M |
| June 30, 2017 | -33.68M |
| March 31, 2017 | -32.16M |
| December 31, 2016 | -27.35M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-108.24M
Minimum
Dec 2021
-27.93M
Maximum
Dec 2023
-82.86M
Average
-90.50M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
| CEL-SCI Corp | -23.07M |
| AIM ImmunoTech Inc | -21.27M |
| IGC Pharma Inc | -6.19M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Protalix BioTherapeutics Inc | -1.318M |